Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

What is oral phynylephrine and why does the FDA want to remove it from cold medicine?

The ingredient has been used for decades by millions of Americans

The Independent UK

Starmer’s reforms to ministerial code do not go far enough, union head says

Dave Penman says any findings of watchdog investigating potential misconduct by top politicians should be binding

The Guardian - UK

RFK's war on public health under Trump

Many experts fear Kennedy’s anti-vaccine and anti-establishment ideals could completely derail public health

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

How RFK Jr.’s health proposals would stack up in practice - Roll Call

Trump ally Robert F. Kennedy Jr. has expressed skepticism about vaccines and vowed to restructure federal health agencies.

Roll Call

FDA Proposes To Ban Popular Decongestant In Cold Medicines Citing 'Not Effective'

Officials clarified that the proposed ban is not related to the safety of oral phenylephrine and companies may continue selling products containing the ingredient until the order is finalized.

Medical Daily

A look at those who could be on Trump’s health team short list - Roll Call

President-elect Donald Trump has pledged to involve anti-vaccine activist and conspiracy theorist Robert F. Kennedy Jr. in his next administration in some capacity, but whoever else he picks to run the major health agencies will have a major impact on the GOP health agenda of the next four years. Top…

Roll Call

RFK Jr. is expected to join Trump's government after warning the 'FDA’s war on public health is about to end,' telling all employees to 'pack your bags'

Kennedy wants to “make America healthy again.”

Fortune

Read news from The Economist, FT, and more,
with one subscription

Robert F. Kennedy Jr. Plans FDA Reform To Tackle Obesity

Robert F. Kennedy Jr. plans FDA reform targeting ultra-processed foods to address health concerns and potential corruption allegations.

Top News

Did Trump Run an Actually Good Campaign?

Plus: New Jersey the swing state, Dick Cheney isn't brat, and more...

Reason

LED device treats leading cause of vision loss with light therapy, FDA says

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

LiveScience

How Elon Musk’s $130 million investment in Trump's victory could reap a huge payoff for Tesla and the rest of his business empire

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Fortune

Over 94,000 illegal Chinese products seized in Bangkok

The Food and Drug Administration has seized more than 94,000 illegal Chinese products from dozens of shops in Bangkok over the past three months.

Bangkok Post

RFK Jr warns he plans on clearing out entire departments of the FDA

Kennedy has made controversial remarks about what he’d do if put in charge of US health care

The Independent UK

3 Defensive Stocks to Buy as Market Volatility Rises

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Latin Times

RFK Jr. Wants To Clear Out 'Entire Departments' at FDA: 'Like the Nutrition Department'

Robert F. Kennedy Jr. stated in an interview that he believes entire departments of the Food and Drug Administration (FDA) are unnecessary and should be dissolved.

StockNews.com

3 Biotech Stocks Predicted to Surge on Medical Innovation

Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, investors might consider adding fundamentally strong biotech stocks like Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Gilead Sciences (GILD) to their portfolio for an impactful investment. Continue reading….

LiveScience

Migraine molecules may drive endometriosis pain. Existing drugs might help.

Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the condition, new research suggests.

Salon

RFK Jr. says he will "clear out" the FDA

President-elect Donald Trump has repeatedly said he would put RFK Jr. in charge of federal health agencies

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Cheeses recalled over listeria risk

The cheeses had “limited regional distribution in the United States,” per an announcement posted by the FDA

The Independent UK

Trump picks Project 2025 co-author to lead FCC as treasury secretary candidates to visit Mar-a-Lago: Live

President-elect chooses Federal Communications Commission Commissioner Brendan Carr to lead body charged with regulating US media

Fortune

LeBron James reportedly spends $1.5 million a year on his biohacking regimen. Here is his daily routine

“I’m surprised at myself at this point," LeBron James says about his stamina on the court.

The Guardian - US

RFK Jr could lead US health and food safety in a second Trump term

Kamala Harris says vaccine skeptic is ‘exact last person’ who should be setting policy for families and children

StockNews.com

3 Biotechnology Stocks With Promising Pipelines

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.

The Independent UK

Woman accused of raking in nearly $1 million by injecting medspa clients with fake Botox

Rebecca Fadanelli paid $50 a vial for the bogus meds, which normally cost $650, according to a federal complaint unsealed Friday

Latin Times

Marco Rubio Demands Two Chinese Pharma Companies be Blacklisted in the U.S. For Ties to Forced Labor

Rubio, alongside Rep Jim McGovern (D-MA), co-sponsored the Uyghur Forced Labor Prevention Act in 2020

1 … 102 103 104 105

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.